Background: Sudomotor dysfunction is one of the earliest pathophysiologic abnormalities in
diabetes. Sudoscan™(Impeto Medical, Paris, France) was developed as a noninvasive …

Objective. The aim of this study was to compare SUDOSCAN, a new device to evaluate
sweat function (reflecting peripheral small C‐fiber status), with conventional measures of …

AIM: The current sudomotor function tests are too time-consuming to be used for diabetic
patients in daily practice. EZSCAN is a new, patented technology that measures …

Background This study evaluated whether measuring the electrochemical skin conductance
(ESC), as an indirect measure of sudomotor function, may be also a reliable surrogate for …

Objective: Sudomotor dysfunction may be an early detectable abnormality in diabetic small
fiber neuropathy. The aim of this study was to evaluate the efficacy of Sudoscan™(Impeto …

Clinical methods of detecting diabetic peripheral neuropathy (DPN) are not objective and
reproducible. We therefore evaluated if SUDOSCAN, a new method developed to provide a …

Purpose Currently available techniques for the evaluation of small fiber neuropathy and
related sudomotor function remain suboptimal. Electrochemical skin conductance (ESC) has …

Diabetic autonomic neuropathy is probably the most undiagnosed but serious complication
of diabetes. The main objectives were to assess the prevalence of peripheral and autonomic …

Purpose Diabetic peripheral neuropathies are the common chronic complications of
diabetes, but the diagnosis is insensitive by physical examination in busy outpatients. Here …

Sudomotor dysfunction is one of the earliest neurophysiologic abnormalities to manifest in
distal small fiber neuropathy. SUDOSCAN® was developed to provide a non invasive, quick …